Armgo Pharma's Series B Round

Armgo Pharma raised a round of funding on August 24, 2011. Investors include Aisling Capital.

Armgo Pharma is a biopharmaceutical company dedicated to the discovery and development of novel small-molecule therapeutics to treat debilitating cardiac, muscular, and neurological disorders. The com…

Articles about Armgo Pharma's Series B Round: